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Abstract
Background: Recently, we reported a neuroprotective effect for Hawthorn (Crataegus oxyacantha) ethanolic extract
in middle cerebral artery occlusion-(MCAO) induced stroke in rats. The present study sheds more light on the
extract’s mechanism of neuroprotection, especially its immunomodulatory effect.
Methods: After 15 days of treatment with Hawthorn extract [100 mg/kg, pretreatment (oral)], male Sprague
Dawley rats underwent transient MCAO for 75 mins followed by reperfusion (either 3 or 24 hrs). We measured pro-
inflammatory cytokines (IL-1b, TNF-a, IL-6), ICAM-1, IL-10 and pSTAT-3 expression in the brain by appropriate
methods. We also looked at the cytotoxic T cell sub-population among leukocytes (FACS) and inflammatory cell
activation and recruitment in brain (using a myeloperoxidase activity assay) after ischemia and reperfusion (I/R).
Apoptosis (TUNEL), and Bcl-xL- and Foxp3- (Treg marker) positive cells in the ipsilateral hemisphere of the brain
were analyzed separately using immunofluorescence.
Results: Our results indicate that occlusion followed by 3 hrs of reperfusion increased pro-inflammatory cytokine
and ICAM-1 gene expressions in the ipsilateral hemisphere, and that Hawthorn pre-treatment significantly (p ≤
0.01) lowered these levels. Furthermore, such pre-treatment was able to increase IL-10 levels and Foxp3-positive
cells in brain after 24 hrs of reperfusion. The increase in cytotoxic T cell population in vehicle rats after 24 hrs of
reperfusion was decreased by at least 40% with Hawthorn pretreatment. In addition, there was a decrease in
inflammatory cell activation and infiltration in pretreated brain. Hawthorn pretreatment elevated pSTAT-3 levels in
brain after I/R. We also observed an increase in Bcl-xL-positive cells, which in turn may have influenced the
reduction in TUNEL-positive cells compared to vehicle-treated brain.
Conclusions: In summary, Hawthorn extract helped alleviate pro-inflammatory immune responses associated with
I/R-induced injury, boosted IL-10 levels, and increased Foxp3-positive Tregs in the brain, which may have aided in
suppression of activated inflammatory cells. Such treatment also minimizes apoptotic cell death by influencing
STAT-3 phosphorylation and Bcl-xL expression in the brain. Taken together, the immunomodulatory effect of
Hawthorn extract may play a critical role in the neuroprotection observed in this MCAO-induced stroke model.
Background
Crataegus oxycantha (Hawthorn) extract is used for the
treatment of heart diseases all over the world. Its bene-
ficial effects have been attributed to the presence of
Oligomeric proanthocyanidins (OPCs) [1]. Our group
has recently shown that an alcoholic extract of Haw-
thorn is able to protect the brain from ischemia/reper-
fusion injury in a rat stroke model [2]. Worldwide,
stroke is the third leading cause of death and the most
frequent cause of long term disability in adults [3].
The immune system plays a vital role during cerebral
stroke and has always been a key area of interest for
scientists. There is mounting evidence that inflamma-
tory mechanisms of the immune system are activated
within hours after cerebral ischemia, representing a key
target for recent translational cerebrovascular research
[4]. Researchers have also shown that animals subjected
to a systemic inflammatory insult at the time of stroke
are predisposed to develop an autoimmune response
against brain tissue, which may be associated with wor-
sened outcome [5].
Damage due to cerebral stroke is not limited to brain.
Stroke has more systemic effects, in that it results in a
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tion phase which is followed by severe immunosuppres-
s i o n ,l i n k e dt oa t r o p h yo ft h es p l e e na n dt h y m u si n
MCAO-induced stroke models in mice [6]. Several
other studies have linked acute stroke to fatal infections.
Vogelgesang et al [7] showed that loss of CD4
+ T cell
activation in stroke patients contributes to stroke-
induced immunosuppression. Chamorro et al [8], in a
clinical study, showed that acute ischemic stroke is asso-
ciated with an early activation of the sympathetic adre-
nomedullary pathway that lowers the threshold for
infection and increases the risk of death.
Several studies have reported on the immunoregula-
tory properties of procyanidins, Miyake et al [9] showed
that OPCs from Jatoba extract exert strong inhibitory
effects in an experimental autoimmune encephalitis
mouse model. Rutin and Chorogenic acid, two polyphe-
nolic antioxidants present in smokeless tobacco extract,
reportedly augment inducible cytokine messages, like
IL-10, and inhibit IgE-mediated mast cell activation [10].
Pentamer to hectamer procyanidin fractions from Cocoa
cause more than 50% inhibition in IL-2 gene expression
in phytohemagglutinin-induced human peripheral blood
mononuclear cells [11].
The immunomodulatory role of Hawthorn extract
(OPC rich) has not been explored. With herbal supple-
ments gaining importance in recent therapeutic strate-
gies, delineating the mechanisms of action for herbal
supplements already used as therapies may increase
their potential uses against different human pathologies.
Previously we have shown that Hawthorn extract pre-
treatment is able to reduce infarct volume and improve
neurological function in MCAO-induced strokes in rats,
and we emphasized the extracts’ antioxidant properties
in that article. Our present goal was to investigate a
potential role for Hawthorn extract in regulating inflam-
matory cascades associated with ischemia/reperfusion-
induced injury.
Methods
Chemicals and reagents
All reagents and chemicals used in this study were of
analytical grade and were purchased from Sigma-Aldrich
(St Louis, MO, USA) unless otherwise mentioned. All
antibodies and isotype controls for FACS analysis were
obtained from BD Biosciences (San Jose, CA).
Animals
The International Animal Care and Use Committee
(IACUC) approved the animal protocol used in this
study. Male Sprague-Dawley rats (Harlan Laboratories
Livermore CA, USA) weighing 300-320 g were used.
Animals were allowed free access to food and water and
were housed at 20°C.
Alcoholic extract of Hawthorn tablets
Each heart care Hawthorn Extract tablet (Nature’sW a y
Products. Incs. Springville, Utah) contains 80 mg of
Hawthorn extract. The tablets were ground to a fine
powder and absolute ethanol was added. This mixture
was allowed to stand overnight at room temperature.
The extract was centrifuged and filtered. This extract
was air dried for 1-2 hours to allow the ethanol to eva-
porate. PBS was added to a final extract concentration
of 100 mg/ml (H-100) of solution.
Treatment groups
Randomly selected animals were used to represent the
following three groups: (A) Sham: used as operated con-
trols with no treatment, (B) Vehicle control: ischemia
for 75 mins followed by 3 or 24 hr of reperfusion and
(C) H-100: Pretreatment (oral, gavage) with Hawthorn
extract 100 mg/kg for 15 days followed by ischemia for
75 mins followed by 3 or 24 hr of reperfusion. The vehi-
cle and sham groups received the same volume of saline
every day for 15 days.
Surgical procedure
Transient focal cerebral ischemia was induced in rats by
subjecting them to MCAO as described previously [12]
with slight modification. Briefly, the rats were initially
anesthetized with 4% isoflurane in 20% oxygen, and
maintained at 2% isoflurane in oxygen during the proce-
dure. Internal body temperature was maintained using
external heating pads during surgery. Under a dissecting
microscope, the right common carotid artery was first
exposed and the occipital branch of the external carotid
artery (ECA) was coagulated by electrocautery. A sili-
con-coated 4.0 monofilament nylon suture (Doccol Cor-
poration, Redland CA) was used for better consistency.
After an opening was made on the ECA, the suture was
inserted through the ECA and into the internal carotid
artery for a distance of 20 mm (in our hands inserting
the suture for 20 mm gave us consistent infarcts for rats
weighing 300-320 gm). The animals were maintained in
this condition for 75 mins of ischemia. After 75 mins,
the suture was removed and normal blood flow was
restored. Animals were then placed in their home cages
to recover from anesthesia.
Measurement of myeloperoxidase (MPO) activity in brain
Brain cerebral cortical tissue obtained after 24 hrs of
reperfusion was used to analyze myeloperoxidase (MPO)
activity according to methods previously described by
Liao et al [13], with slight modifications. Briefly, 50 ul of
protein extract (Total protein concentration was 1.6 mg/
ml for all groups), was added to each well of an ELISA
plate followed by 250 μl of assay buffer (26.9 ml of
water, 3 ml of 0.1 M sodium phosphate buffer (pH 7.0),
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These were mixed and the kinetics of the reaction was
followed for 1 min with a spectrophotometer at 470 nm.
Quantification of IL-10 in brain samples
We isolated brain tissue from rats following 75 mins of
occlusion and 24 hrs of reperfusion. The tissue samples
were homogenized and IL-10 ELISA was performed
using a kit from BD Biosciences (San Jose, CA). The
manufacturer’s protocol was followed to analyze IL-10
concentration in brain homogenates. IL-10 levels were
expressed as picograms/0.1 mg of total protein.
RNA isolation and reverse transcription
RNeasy Mini kit from Qiagen (Valencia, CA) was used
for the isolation of RNA from brain tissue. Total RNA
was extracted from the brain according to the manufac-
turer’s protocol. We used a Quantitect kit from Qiagen
(Valencia, CA) for genomic DNA removal and reverse
transcription.
TaqMan real-time PCR in brain tissue
Relative real-time RT-PCR analysis of IL-1b,T N F - a,I L -
6, ICAM-1 and rpL32 (as a house keeping gene) were
performed using a protocol previously described by Berti
et al, [14], with slight modifications. The primers and
probes (Applied Biosystems, Foster City, CA) used in this
study are reported in Table 1. 6-Carboxyflurescin (FAM)
was used as the reporter dye; 6-carboxy-tetramethyl-rho-
damine (TAMRA) was the quencher dye. Real-time PCR
was performed using TaqMan Universal PCR master Mix
(Applied Biosystems, Foster City, CA). A 20 X stock solu-
tion of primers (18 μM) and probes (5 μM) was prepared
separately for each gene. Two-to-five nanograms of
cDNA were used in each reaction. Amplification condi-
tions included 2 mins at 50°C and 10 mins at 95°C, fol-
lowed by a run for 40 cycles at 95°C for 15 seconds and
60°C for 1 min on 7900 HT sequence detection system,
ABI Prism (Applied Biosystems, Foster City, CA).
Fluorescent activated cell sorting (FACS) analysis
Peripheral blood cells were isolated from all groups after
24 hrs of reperfusion, washed and incubated with mono-
clonal antibodies for a cytotoxic T cell sub population
(CD3
+ CD8
+ T cells). We used PE-mouse anti-rat CD8a
a n dF I T C - m o u s ea n t i - r a tC D 3f o rt h i sp u r p o s e .P E -
mouse IgG1, K and FITC-mouse IgG3, K were used as
the respective isotype negative controls. All antibodies
and isotype controls were obtained from BD Pharmin-
gen (San Jose, CA). FACS analysis was performed using
“Cytomics FC 500 MPL” from Beckman Coulter (Brea,
CA). Stained cells were expressed as a percentage of
total leukocytes, after subtraction of their respective
negative isotype controls.
Western blot analysis
Tissue samples were first washed with ice-cold phosphate-
buffered saline (PBS) and homogenized using T-PER buf-
fer with protease and Halt-Phosphatase inhibitor cocktail
(Pierce Chemical, Rockford, IL). The homogenates were
centrifuged at 5000 rpm at 4
ο C for 10 min, to remove cell
debris. All samples were assayed for protein concentration
using a BCA assay (Pierce Chemical, Rockford, IL), after
which the samples were stored at -80°C until use. Proteins
were separated by SDS-polyacrylamide gel electrophoresis
and transferred to a polyvinylidene difluoride membrane.
The membrane was blocked with 5% bovine serum albu-
min (BSA) in PBS/Tween 20 solution. The blots were
incubated with (Signal Transducer and activator of tran-
scription) phospho-STAT-3 (pSTAT-3), STAT3 (Cell sig-
naling Technology, Inc. Danvers, MA) and b-actin (Sigma-
Aldrich St. Louis, MO) antibodies. After washing with
PBS/Tween 20 solution, the blots were incubated with
appropriate horseradish peroxidase- (HRP-) conjugated
secondary antibodies, followed by development using an
Enhanced Chemiluminescence detection kit (GE Health-
care, Chalfont St.Giles, Buckinghamshire, UK).
Immunofluorescent staining
Rat brains were harvested after 3 or 24 hrs of reperfusion.
They were then paraffin-embedded and sectioned. The
sections were stained to determine the expression levels
of Foxp3 and Bcl-xL, using methods previously described
by Khan et al [15] with slight modifications. Briefly,
Table 1 Details of primers (forward & reverse) and
probes for different genes used for real -time PCR
analysis.
Gene Primer/Probe Sequences
IL-1b Primer (forward) 5’-CAC CTC TCA AGC AGA GCA CAG-3’
Primer (reverse) 5’-GGG TTC CAT GGT GAA GTC AAC-3’
Probe
(antisense)
5’-TGT CCC GAC CAT TGC TGT TTC CTA GG-3’
TNF-a Primer
(forward)
5’-CCA GGA GAA AGT CAG CCT CCT-3’
Primer (reverse) 5’-TCA TAC CAG GGC TTG AGC TCA-3’
Probe
(antisense)
5’-AGA GCC CTT GCC CTA AGG ACA CCC
CT-3’
IL-6 Primer (forward) 5’-CGAAAGTCAACTCCATCTGCC-3’
Primer (reverse) 5’-GGCAACTGGCTGGAAGTCTCT-3’
Probe (sense) 5’-TCAGGAACAGCTATGAAGTTTCTCTCCG-3’
ICAM-1 Primer (forward) 5’-AAACGGGAGATGAATGGTACCTAC-3’
Primer (reverse) 5’-TGCACGTCCCTGGTGATACTC-3’
Probe (sense) 5’-TGCCGTGCCTTTAGCTCCCGTG-3’
rpL32 Primer (forward) 5’-TGT CCT CTA AGA ACC GAA AAG CC-3’
Primer (reverse) 5’-CGT TGG GAT TGG TGA CTC TGA-3’
Probe (sense) 5’-TCG TAG AAA GAG CAG CAC AGC TGG
CC-3’
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antigen unmask solution from Vector Labs (Burlingame,
CA) using the manufacturer’s protocol. After antigen
unmask, the slides were blocked with 10% goat normal
serum and permeabilized with 0.01% triton X100 in PBS,
followed by primary antibody incubation with either
FITC conjugated Foxp3 (eBioscience, San Diego, CA)
(1:100 dilution) or rabbit anti-Bcl-xL (Cell Signaling
Technology, Inc. Danvers, MA) (1:100 dilution). Bcl-xL
primary antibody-treated slides were then washed (with
0.01% tween20 in PBS) and incubated with secondary
antibody (goat anti-rabbit IgG-FITC) (1:300 dilution). All
slides were then washed and mounted with vector shield
mounting media with DAPI from Vector Labs (Burlin-
game, CA). The slides were observed with an Olympus
1X81 microscope and images were processed using
Adobe Photoshop software (San Jose, CA). Using image J
analysis software http://rsbweb.nih.gov/ij/, all images
were converted into binary images then Foxp3/Bcl-xL-
positive cells were counted and analyzed. Areas were ran-
domly selected from 3-5 sections (for each animal) to
obtain counts of positively stained cells, which were then
normalized to the sham group and plotted as fold change.
TUNEL staining
Terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) was performed using a kit from Che-
micon (Billerica, MA). The manufacturer’s instructions
were followed for processing and staining of sections.
Finally, all slides were then washed and mounted with
vector shield mounting media with DAPI from Vector
Labs (Burlingame, CA). The slides were observed with
an Olympus 1X81 microscope and images were pro-
cessed using Adobe Photoshop software (San Jose, CA).
TUNEL-positive cells were counted using Image J analy-
sis software http://rsbweb.nih.gov/ij/, as described above.
Areas in and around the penumbra were randomly
selected from 3-5 sections (for each animal) to obtain
counts of positively stained cells, which were then nor-
malized to sham group and plotted as fold change.
Statistics
Graphpad Prism 5.0 version (GraphPad software, San
Diego CA, USA) was used to perform statistical calcula-
tions. Data were compared using one way ANOVA fol-
lowed by Bonferroni post-hoc analysis. A ‘p’ value of
less than 0.05 was considered significant, all values were
represented as mean ± SD for n determination.
Results
MPO activity assay
Myeloperoxidase (MPO) is the most abundant enzyme
in neutrophils, it is also present in monocytes, and is
considered to be a primary focus of inflammatory
pathologies. MPO assays performed on ipsilateral corti-
cal brain samples after 24 hrs of I/R showed a signifi-
cant increase in activity in vehicle-treated rats versus
sham operated animals. Hawthorn extract treatment sig-
nificantly (p ≤ 0.01) decreased this activity (Figure 1),
suggesting that Hawthorn-pretreated cortical brain tis-
sue had decreased exposure to potential tissue damaging
cells such as neutrophils or other inflammatory cells.
IL-10 levels in brain
IL-10 is an immuno-suppressant that is mainly secreted
by regulatory T cells. We found IL-10 levels to be signif-
icantly (n = 6 per group; p ≤ 0.01) lower in ipsilateral
brain after 24 hrs of reperfusion in the vehicle group,
compared to sham. However, Hawthorn extract was
able to maintain IL-10 expression close to levels
observed in sham (Figure 2), possibly by enhancing the
presence or activity of regulatory T cells in the brain.
The contralateral IL-10 levels in vehicle and Hawthorn-
pretreated groups were found to be similar.
RT-PCR of proinflammatory mediators
TNF-a,I L - 1 b, IL-6 and ICAM-1 gene expressions were
studied in different regions of brain (striatum and cortex)
after 3 hrs of reperfusion. The vehicle control group
showed a significant fold increase (n ≥ 6p e rg r o u p ;p ≤
0.01) in the above mentioned genes in the striatum of the
ipsilateral hemisphere when compared to Hawthorn-trea-
ted group. We also observed a significant reduction in
the induction of both TNF-a and IL-1b mRNA in the
cortex of treated brain (8.7 and 1.9 fold, respectively).
However we did not observe a significant difference
between vehicle and treated groups for expression of the
IL-6 gene, in the cortex region (Figure 3).
FACS analysis for cytotoxic T cells
The circulating cytotoxic T cell subpopulation (CD3
+
CD8
+ cells) is a good indicator of systemic immune
response to I/R injury. The cells could potentially enter
the brain through a leaking blood-brain barrier or even
through blood vessels with the help of adhesion mole-
cules. Peripheral blood mononuclear cells (PBMCs) were
stained for this cytotoxic T cell sub-population. In our
hands the percentage of cytotoxic T cells was found to be
significantly increased in vehicle group when compared
to sham group (n ≥ 4p e rg r o u p ;p ≤ 0.01). Hawthorn
pretreatment significantly reduced these levels (Figure 4).
Hawthorn pretreatment increases STAT-3 phosphorylation
in rat brain after I/R
After 24 hrs of reperfusion there was an increase in
STAT-3 phosphorylation in Hawthorn-pretreated brain.
Though the levels in vehicle ipsilateral hemisphere were
higher than sham group, they were significantly less
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Page 4 of 13Figure 1 Myeloperoxidase (MPO) activity assay in cortical (ipsilateral) brain after 24 hrs of reperfusion. The graph is a representation of
n = 5 experiments and results are expressed as % of Sham. “a” for p ≤ 0.01 when compared to sham. “b” for p ≤ 0.01 when compared to
vehicle group, “c” for p ≤ 0.01 when compared to H-100 IP group and ,"d” for p ≤ 0.01 when compared to H-100 Contra group.
Figure 2 Interleukin-10 levels in ipsilateral brain tissue after 24 hrs of reperfusion. Data represented as mean ± SD (n = 6). IL-10 levels are
expressed as picograms/0.1 mg of total protein. “a” for p ≤ 0.01 when compared to sham. “b” for p ≤ 0.01 when compared to vehicle group, “c”
for p ≤ 0.01 when compared to H-100 IP group and ,"d” for p ≤ 0.01 when compared to H-100 Contra group.
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Page 5 of 13Figure 3 Proinflammatory cytokine and ICAM-1 expression levels in striatum/cortex of the ipsilateral brain after ischemia followed by
3 hrs of reperfusion. Bar graphs (a) TNF-a, (b) IL-6, (c) IL-1b and (d) ICAM-1 indicate expression levels (fold increases) as mean ± SD (n ≥ 6) for
two different experiments. Data represented as fold increase normalized to respective contralateral side; “a” for p ≤ 0.05 when sham compared
to other groups; “b” for p ≤ 0.05 when vehicle striatum (st) compared with H-100 striatum (st) and “c” for p ≤ 0.05 when vehicle cortex (cort)
compared to H-100 cortex (cort).
Figure 4 Fluorescence assorted cell sorting analysis of cytotoxic T cells (CD3
+ CD8
+). Data presented as mean ± SD (n ≥ 4) CD3- & CD8-
positive cells as a percentage of total leukocytes; “a” for p ≤ 0.05 when compared to sham group; “b” for p ≤ 0.05 when compared to vehicle
group.
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brain. This was observed in both cortex and striatum
regions of brain. However, total endogenous STAT-3
expression was unchanged (Figure 5).
Immunofluorescent staining in brain sections
Vehicle control rat brain sections obtained after 3 hrs of
reperfusion showed very few Foxp3-positive cells
(stained in green) in the ipsilateral hemisphere (striatum
and cortex). However, we found a larger number of cells
to be Foxp3-positive in the same regions of Hawthorn-
pretreated rats (Figure 6). Bcl-xL staining was performed
in brain sections after 24 hrs of reperfusion (Figure 7),
a n ds h o w e da ni n c r e a s ei nt h en u m b e ro fB c l - x L - p o s i -
tive cells (stained in green) in the H-100 group com-
pared to the vehicle control group. Images were
captured in regions that appeared to have equal num-
bers of brain cells (indicated by their nuclei, stained in
blue) across different groups. All photographic images
were taken at a 200 × magnification.
TUNEL assay in brain tissue
Programmed cell death plays a pivotal role in the loss of
brain cells during I/R. We used TUNEL staining to look
for apoptotic cells in and around the penumbra of the
ipsilateral hemisphere. After 24 hrs of reperfusion, sec-
tions from vehicle-treated rat brain, showed a significant
increase in TUNEL-positive cells in the penumbra of
ipsilateral hemisphere, compared to sham brain tissue.
Hawthorn pretreatment was able to reduce TUNEL-
positive cells following I/R-induced injury (Figure 8).
Discussion
Activation of an inflammatory response is considered to
be a key event associated with most human pathologies
like stroke and atherosclerosis [16,17]. Alleviating the
immune response has been found to be favourable in the
prognosis of such disorders [18]. Furthermore, Fu et al
[19] showed an increase in proinflammatory cytokine
expression in lumbosacral spinal cord and urinary blad-
der of rats that were subjected to transient and
Figure 5 Western blot analysis of pSTAT-3/STAT-3 expression in tissue after 24 hrs of reperfusion. Representative blot image of pSTAT-3/
STAT-3 in cortex (a) and striatum (b). The last panel shows bands for b-actin in the respective samples. Also shown are graphical presentation of
results indicated as relative densities (pSTAT-3/STAT-3) for cortex (c) and striatum (d). Relative densities are presented as mean ± SD (n = 4); “a”
for p ≤ 0.01 when compared to sham group; “b” for p ≤ 0.01 when compared to vehicle group.
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of infarct, suggesting neural death may influence spinal
cord and urinary bladder dysfunction in clinical stroke.
Apart from this, CNS injury can lead to secondary immu-
nodeficiencies resulting in infections [20]. With several
immune system-related factors (cytokines, leukocytes,
etc) known to affect the brain and other organs during
ischemia/reperfusion injury, a clear understanding of the
mechanisms and functions of these factors could be key
for developing beneficial therapeutic strategies. A suc-
cessful therapeutic strategy would include suppression of
proinflammatory cytokines, decreased autoimmunity to
CNS antigens, increases in anti-inflammatory cytokines,
reduction in the recruitment of inflammatory cells, etc.
Previously, our lab established the neuroprotective effect
of Hawthorn extract in a rat stroke model [2]. Here, we
studied different immune responses occurring during
ischemia/reperfusion in vehicle- and Hawthorn extract-
pretreated brain. We used the MCAO-induced cerebral
ischemia/reperfusion injury model for this study. The
degree of injury was consistent with an occlusion period
of 75 minutes and, by using commercially available
sutures for occluding the MCA, we had a 26% mortality
rate with this model.
Animal models of cerebral stroke indicate that inter-
fering with the inflammatory response that occurs dur-
ing brain I/R injury may be beneficial [21,22]. Preclinical
evidence also demonstrates that immune system toler-
ance to central nervous system (CNS) antigens improves
outcome from stroke [23,24]. Injury to the CNS disturbs
Figure 6 Foxp3 immunofluorescent staining in brain after 3 hrs of reperfusion. Photographs show Foxp3 staining in striatum (a) and
cortex (b) regions of brain in all three groups (Sham, Vehicle and H-100). Green staining represents Foxp3-positive cells, and DAPI (which stains
the nucleus) is in blue. A merged image of DAPI and Foxp3 to indicate cell-specific staining for each group is also shown. Images were taken at
200 × magnification. Scale bar = 80 μm. Graphical representation of Foxp3-positive cell counts in striatum (c) and cortex (d) regions, indicated as
sham-normalized fold change are also shown; “a” for p ≤ 0.05 when compared to sham group; “b” for p ≤ 0.05 when compared to vehicle
group.
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and the CNS [25], which results in further tissue
damage through aberrant activation of the immune sys-
tem. Studies have shown that ischemia/reperfusion
injury induces expression of cell adhesion molecules and
cytokines in the brain through activation of the nuclear
transcription factor, NF-B [14]. It is well established
that NF-B is activated during MCAO-induced I/R
injury. Reducing its activity is associated with reduction
in infarct volume after MCAO [26]. NF-Bi sm a i n l y
Figure 7 Immunofluorescent staining for Bcl-xL in and around the penumbra of ipsilateral brain after 24 hrs of reperfusion.
Representative images of Bcl-xL-positive cells (FITC - green fluorescence) along with nuclear staining (DAPI - blue) in Sham, Vehicle and H-100
groups. A merged image of DAPI and Bcl-xL to indicate cell specific staining for each group is also shown. Images were taken at 200 ×
magnification. Scale bar = 80 μm. A graphical representation of Bcl-xL-positive cell counts, indicated as sham-normalized fold change is also
shown; “a” for p ≤ 0.05 when compared to sham group; “b” for p ≤ 0.05 when compared to vehicle group.
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has been found to mediate its neuroprotective effect in
the MCAO model by blocking TNF-a-induced activa-
tion of NF-B [27]. In our model, proinflammatory
cytokines (TNF-a,I L - 6a n dI L - 1 b) were induced after 3
hrs of reperfusion in different regions of the ipsilateral
vehicle-treated brain, and Hawthorn extract significantly
decreased their induction by at least 1.3-fold in striatum.
This may have resulted in decreased NF-B activation
thereby reducing further damage to the brain. Microglial
cells are the main source of TNF-a and IL-1b. A signifi-
cant reduction in TNF-a and IL-1b expression in the
Hawthorn extract-treated group may indicate a suppres-
sion of resident microglial cell activation by the extract.
Foxp3-positive regulatory T Cells (Tregs) are important
for maintaining peripheral tolerance, preventing autoim-
mune diseases and limiting chronic inflammatory dis-
eases [28,29]. One of the mechanisms by which Tregs
mediate their suppressive effect is by secreting inhibitory
cytokines such as IL-10. IL-10 is well known for its
positive effects in cerebral ischemia in rats [30].
Hawthorn pretreatment was able to significantly
increase IL-10 protein expression in ipsilateral brain by
at least 30% when compared to vehicle-treated rats after
24 hrs of reperfusion. Furthermore, Foxp3 (marker for
Tregs) staining in brain sections from animals with 3 hr
of reperfusion complemented the IL-10 results, in that
we observed increased Foxp3 staining in H-100-treated
ipsilateral brain when compared to vehicle-treated tis-
sue. The abundance of Tregs in Hawthorn-treated brain
following I/R may have influenced the increased expres-
sion of IL-10. In addition, Tregs can be induced, adapted
or converted from effector T cells during inflammatory
processes in peripheral tissues for therapeutic purposes
[31-33], especially the IL-10-secreting T regulatory type
1( T r1), defined by their specific cytokine production
profile (both IL-10 and transforming growth factor-b).
These cells also have the ability to suppress antigen-spe-
cific effector T cell responses via their cytokine-depen-
dent mechanisms. However, Tr1 cells do not express
Foxp3. The significantly elevated levels of IL-10 in Haw-
thorn-pretreated brain in our model indicates the
Figure 8 TUNEL staining representing apoptotic cells in and around the penumbra of ipsilateral brain after 24 hrs of reperfusion in all
three groups (Sham, Vehicle and H-100). The green staining represents TUNEL-positive cells. Images were taken at 100 × magnification. Scale
bar = 80 μm. A graphical representation of TUNEL-positive cell counts, indicated as sham-normalized fold change is also shown; “a” for p ≤ 0.05
when compared to sham group; “b” for p ≤ 0.05 when compared to vehicle group.
Elango and Devaraj Journal of Neuroinflammation 2010, 7:97
http://www.jneuroinflammation.com/content/7/1/97
Page 10 of 13possible involvement of Tr1 cells in addition to Tregs.
These cells are also capable of antagonizing the produc-
tion of proinflammatory cytokines (TNF-a and IFNg),
that induce secondary brain damage during stroke [34].
Therefore, Hawthorn extract not only improved anti-
inflammatory response but also suppressed the proin-
flammatory immune response and secondary brain
damage. Our results indicate that Tregs may have a criti-
cal role in this immunomodulatory response.
Myeloperoxidase, abundantly present in neutrophils,
produces hypochlorous acid from hydrogen peroxide
and chloride ion during the neutrophils’ respiratory
burst (abundance of reactive oxygen species). Hypo-
chlorous acid is highly cytotoxic and has been demon-
strated to damage CNS tissue during inflammation [35].
Further, myeloperoxidase activity assay has been suc-
cessfully used to confirm inflammatory cell activation
and recruitment in brain after MCAO [13]. We per-
formed this assay to establish a relationship between the
neuroprotective effect of Hawthorn extract and its
immunomodulatory properties in MCAO-induced brain
injury (cortex) after 24 hrs of reperfusion. As expected,
there was a significant increase (28%) in MPO activity in
vehicle brain (ipsilateral cortex) when compared to
sham group. Hawthorn pretreatment was able to reduce
this activity to the levels observed in sham (Figure 1).
This indicates that there was a significant suppression of
neutrophil activation and recruitment leading to less tis-
sue damage.
Intracellular adhesion molecule-1 (ICAM-1) is essen-
tial for the recruitment and trafficking of leukocytes
through vessels and in T cell/macrophage interactions
[36]. A recent review describes how adhesion molecules
in general have effects on infarct size in the MCAO
model [37]. Another group has shown that the neuro-
protective effect of the antioxidant caffeic acid phenyl
ester is partly due to its ability to minimize the expres-
sion of I/R-induced ICAM-1 [15]. In our study, the
observed increase in ICAM-1 gene expression in ipsilat-
eral brain after 3 hrs of reperfusion in vehicle treated
group was decreased with H-100 pretreatment. This
may have minimized leukocyte trafficking to the brain.
To better understand the neuroprotective mechanism
offered by Hawthorn extract we looked at STAT-3
phosphorylation after 24 hrs of reperfusion in ipsilateral
brain. H-100-pretreated rats showed significantly higher
levels of phosphorylated STAT-3 when compared to
vehicle-treated rats, while in the sham group no phos-
phorylation was detected. H-100 pretreatment did not
have any effect on the basal expression of STAT-3; all 3
groups had similar STAT-3 levels after 24 hrs of reper-
fusion. Dziennis et al [38] has shown pSTAT-3 to be a
positive modulator in the neuroprotective function
offered by estradiol in a similar stroke model. They
claim that, in the estradiol-treated group, STAT-3 is
phosphorylated and translocates into the nucleus to pro-
mote transcription of the Bcl-2 family of proteins. Thus,
we probed for Bcl-xL, one of the anti-apoptotic mem-
bers of Bcl-2 family proteins to see if this was the case
in our model. As seen in figure 7, immunofluorescent
staining performed in brain sections from animals after
24 hr of reperfusion showed that, in comparable regions,
H-100-treated brain expressed higher levels of Bcl-xL
than vehicle-treated brain. We further performed
TUNEL staining of brain tissue to see if higher Bcl-xL
expression in the treated group translated to an anti-
apoptotic effect. As expected, there was a significant
increase in TUNEL-positive cells in ipsilateral vehicle-
treated brain sections after 24 hrs of reperfusion, com-
pared to the sham group, However, H-100 pretreatment
was able to significantly decrease the number of
TUNEL-positive cells to close to levels observed in the
sham group (Figure 8). Apoptotic cell death can also
occur by modulation of caspases. Granzyme-b, a serine
protease found in the cytoplasmic granules of cytotoxic
T cells, plays a vital role by activating several caspases
and by initiating caspase-independent pathways that
contribute to target cell death [39]. In the present study,
the CD3
+ CD8
+ cytotoxic T cell population was signifi-
cantly increased in the vehicle-treated group after I/R,
However this cell population was reduced by at least
1.7-fold in the pretreated group (Figure 4), which may
have reduced granzyme-b and caspase activation,
thereby decreasing the cytotoxic T cell population in
brain and contributing to reduced neuronal death due
to apoptosis. This may explain the low level of TUNEL-
positive cells seen in the pretreated group.
About 700,000 people suffer from stroke in America
each year, and 200,000 of these are recurrent strokes
[40]. A recent study has also shown that nearly two-
thirds of stroke patients who are discharged after having
an attack will die or be readmitted to the hospital within
ay e a r .T h i ss t u d ya n a l y z e di s c h e m i cs t r o k ei n c i d e n c e s
from 625 hospitals from the US and reported the read-
mission rate as 62% within a year of the first stroke.
Furthermore, patients who are in the high-risk category
for stroke, such as those with hypertension, diabetes,
dyslipidemia, etc; also form a significant proportion of
the population [41]. These facts show the importance of
controlling risk factors either through diet or treatment
in this high risk group. Our present study shows that
Hawthorn extract may be beneficial in patients prone to
stroke by decreasing some of the immune system-
mediated damage to the brain during stroke. Oxidative
stress and an increase in ROS have been hallmark fea-
tures associated with stroke, and Hawthorn extract pre-
treatment has been shown to decrease oxidative stress
and associated damage [2]. Adding to this, Hawthorn
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extensively used and well advocated as an oral treatment
option for chronic heart failure. According to the New
York Heart Association, the German Commission E has
approved the use of Hawthorn extract (leaf and flower)
by patients suffering from heart failure graded stage II
[42]. A review of 14 double-blind, placebo-controlled,
randomised clinical trials (RCTs) found that, in addition
to conventional drugs, oral treatment of Hawthorn
extract could be an option for chronic heart failure [42].
The daily dose used in these clinical trials ranged
between 160 mg and 1800 mg. Our results from the
current and previous studies indicate that Hawthorn
extract has beneficial anti-inflammatory and antiapopto-
tic effects in a cerebral stroke model, and this suggests
that people who are prone to stroke or who have suf-
f e r e dt h e i rf i r s ts t r o k em a ypotentially benefit from an
oral pretreatment schedule with Hawthorn extract.
Further clinical studies are essential to determine the
clinical impact and exact dose.
Conclusions
In summary, we observed decreased neutrophil and CD3
+CD8
+ cytotoxic T cell activity in Hawthorn extract-pre-
treated animals following I/R. There was also a significant
down-regulation of pro-inflammatory mediators (TNF-a,
IL-6, IL-1b and ICAM-1) in brain. We found that Haw-
thorn pretreatment helped increase the regulatory T cell
population in brain following ischemia/reperfusion injury.
These cells mediated their immunosuppressive role with
the help of IL-10, which was also found to be elevated in
pretreated brain. Phosphorylation of STAT-3 in brain of
the Hawthorn-treated group was elevated, which may have
helped to minimize apoptosis in brain during reperfusion.
Taken together, our results suggest that Hawthorn extract
has an immunomodulatory effect that plays a crucial role in
the observed neuroprotection after MCAO-induced stroke.
However, further studies are needed to clarify the mechan-
ism of this immunomodulatory effect of Hawthorn extract.
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